KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Royalty Pharma (RPRX) Profit After Tax (2019 - 2025)

Historic Profit After Tax for Royalty Pharma (RPRX) over the last 7 years, with Q3 2025 value amounting to $444.2 million.

  • Royalty Pharma's Profit After Tax fell 4491.14% to $444.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 2440.19%. This contributed to the annual value of $1.3 billion for FY2024, which is 2172.09% down from last year.
  • As of Q3 2025, Royalty Pharma's Profit After Tax stood at $444.2 million, which was down 4491.14% from $90.6 million recorded in Q2 2025.
  • In the past 5 years, Royalty Pharma's Profit After Tax ranged from a high of $806.8 million in Q2 2021 and a low of -$610.0 million during Q4 2022
  • In the last 5 years, Royalty Pharma's Profit After Tax had a median value of $221.8 million in 2021 and averaged $288.4 million.
  • Per our database at Business Quant, Royalty Pharma's Profit After Tax plummeted by 123661.01% in 2022 and then skyrocketed by 897143.16% in 2025.
  • Over the past 5 years, Royalty Pharma's Profit After Tax (Quarter) stood at $53.7 million in 2021, then crashed by 1236.61% to -$610.0 million in 2022, then soared by 217.63% to $717.6 million in 2023, then tumbled by 53.41% to $334.4 million in 2024, then soared by 32.86% to $444.2 million in 2025.
  • Its Profit After Tax stands at $444.2 million for Q3 2025, versus $90.6 million for Q2 2025 and $433.4 million for Q1 2025.